CompletedNot Applicable

Evaluation of the Effect of Animated Video-Assisted Nutrition Education on Heart Failure Patients

Turkey (Türkiye)70 participantsStarted 2025-06-16

Plain-language summary

This randomized controlled trial aims to evaluate the effect of animation video-supported nutrition education on dietary behaviors, symptom severity, and quality of life in patients with heart failure. A total of 70 patients aged 45-60 years with NYHA class II or III heart failure will be recruited at Tokat Gaziosmanpaşa University Research and Application Hospital Cardiology Clinic. Participants will be randomly assigned to an intervention group, which will receive video-supported nutrition education, or a control group, which will receive standard care. Outcomes will be assessed using the Heart Failure Dietary Behavior Scale, Heart Failure Symptom Status Scale, and Minnesota Living with Heart Failure Questionnaire at baseline, 1 month, 3 months, and 6 months.

Who can participate

Age range

45 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Individuals who have been diagnosed with heart failure at least six months ago, * Are between the ages of 45-60, * Are in NYHA stage II or III, * Have a mobile phone capable of watching videos, * Volunteer to participate in the study will be included in the study. Exclusion Criteria: Individuals with HF who were included in the study as a sample, * Patients with fluid restriction under a different protocol (e.g., Chronic Renal Failure), * Patients with chronic pulmonary disease (e.g., COPD), * Illiterate, * Do not own a mobile phone capable of watching videos, * Have physical or cognitive impairments, * Have a psychiatric illness, * Refuse to participate in the study will not be included in the study. * Patients hospitalized during the study period will be excluded from the study, and their data will not be subject to statistical analysis.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Mean Score on the Heart Failure Dietary Behavior Scale

Timeframe: At baseline, 1 month, 3 months, and 6 months

Trial details

NCT IDNCT07305272

SponsorTokat Gaziosmanpasa University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-01

View on ClinicalTrials.gov More Heart Failure trials